Global Hypertension Management Devices Market, By Technology (Radiofrequency Ablation, Ultrasound, Micro-Infusion, Others), Product (Renal Denervation Devices, Carotid Sinus Stimulation Devices, Respiratory Modulation Devices), Application (Hospitals, Clinics, Home Care) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights of Hypertension Management Devices Market
Data Bridge Market Research analyses that the hypertension management devices market to account USD 9.50 billion by 2029 by growing at a CAGR of 7.27% in the forecast period of 2022-2029.
Hypertension management devices are the medical devices that are presently underneath development and clinical trials from the key market players, though many variants are still out there. These medical devices are being developed with the main focus on managing the cardiovascular diseases and disorders amongst humans in an exceedingly simpler and economical manner due to the shortage of any effective medicine out there.
The rising volume of patients suffering from hypertension associated disorders amid unmet clinical needs of these patients is the major factor accelerating the growth of the hypertension management devices market in the forecast period of 2022-2029. Furthermore, lack of effective management therapies is also expected to drive the growth of the hypertension management devices market in the forecast period of 2022-2029. However, the lack of insurance coverage and the high price will restrain the growth of hypertension management devices market in the forecast period of 2022-2029, whereas, medical conditions that have increased risk of developing heart diseases and causing strokes will challenge market growth in the forecast period of 2022-2029.
In addition, increasing attainment of positive clinical data from the various clinical trials and growing rate of awareness will create ample opportunities for the hypertension management devices market in the above mentioned forecast period.
This hypertension management devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hypertension management devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hypertension Management Devices Market Scope and Market Size
The hypertension management devices market is segmented on the basis of technology, product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology, the hypertension management devices market has been segmented into radiofrequency ablation, ultrasound, micro-infusion and others.
- Based on product, the hypertension management devices market has been segmented into renal denervation devices, carotid sinus stimulation devices and respiratory modulation devices.
- Hypertension management devices market has been segmented on the basis of application into hospitals, clinics and home care.
Hypertension Management Devices Market Country Level Analysis
The hypertension management devices market is analysed and market size insights and trends are provided by country, technology, product and application as referenced above.
The countries covered in the hypertension management devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hypertension management devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to rise in prevalence of hypertension as well as resistant hypertension, presence of major players, and increase in adoption of advanced devices to monitor hypertension. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to increase in the geriatric population suffering with hypertension, rise in adoption of new treatment procedure to manage hypertension, surge in health care expenditure, and increase in awareness among people about preventive health care in this region.
The country section of the hypertension management devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The hypertension management devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hypertension management devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hypertension management devices market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Hypertension Management Devices Market Share Analysis
The hypertension management devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hypertension management devices market.
Some of the major players operating in the hypertension management devices market report are Pfizer Inc., Amgen Inc., Cytokinetics, Inc., Hikma Pharmaceutical PLC., AbbVie Inc., Lupin Ltd., Wockhardt, Glenmark., Zydus Pharmaceutical Inc., Amneal pharmaceutical LLC., Accord Healthcare., Aurobindo Pharma, Abbott, Medtronic, BD, Cook, Takeda Pharmaceutical Company Limited and Sun Pharmaceutical Industries Ltd among others.
SKU-